{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:32:07Z","timestamp":1760149927923,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4913,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jpainsymman.2006.02.014","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T02:01:00Z","timestamp":1154224860000},"page":"191-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful Palliation with Octreotide of a Neuroendocrine Syndrome from Malignant Melanoma"],"prefix":"10.1016","volume":"32","author":[{"given":"Alexander W.","family":"Jahng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon S.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpainsymman.2006.02.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/erc.0.0110001","article-title":"Neuroendocrine tumours","volume":"11","author":"Barakat","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2006.02.014_bib2","first-page":"iv1","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jpainsymman.2006.02.014_bib3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.jpainsymman.2006.02.014_bib4","first-page":"1184","article-title":"Emerging indications for octreotide therapy, Part 1","volume":"51","author":"Mosdell","year":"1994","journal-title":"Am J Hosp Pharm"},{"issue":"Suppl 2","key":"10.1016\/j.jpainsymman.2006.02.014_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000051479","article-title":"Octreotide in the treatment of refractory diarrhea","volume":"60","author":"Fried","year":"1999","journal-title":"Digestion"},{"issue":"5","key":"10.1016\/j.jpainsymman.2006.02.014_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1191\/026921699677473561","article-title":"Octreotide as an agent for the relief of malignant ascites in palliative care patients","volume":"13","author":"Cairns","year":"1999","journal-title":"Palliat Med"},{"issue":"6","key":"10.1016\/j.jpainsymman.2006.02.014_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0885-3924(94)90178-3","article-title":"The role of octreotide in palliative care","volume":"9","author":"Mercadante","year":"1994","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jpainsymman.2006.02.014_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1191\/0269216303pm698oa","article-title":"Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire","volume":"17","author":"Pistevou-Gombaki","year":"2003","journal-title":"Palliat Med"},{"issue":"5","key":"10.1016\/j.jpainsymman.2006.02.014_bib9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1345\/aph.10316","article-title":"Octreotide for acute variceal bleeding","volume":"35","author":"Erstad","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.jpainsymman.2006.02.014_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2168.2001.01659.x","article-title":"Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials","volume":"88","author":"Li-Ling","year":"2001","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.jpainsymman.2006.02.014_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF02482785","article-title":"Management of severe acute pancreatitis with a somatostatin analog in a patient undergoing surgery for dissecting thoracic aneurysm: report of a case","volume":"29","author":"Matsumoto","year":"1999","journal-title":"Surg Today"},{"issue":"2","key":"10.1016\/j.jpainsymman.2006.02.014_bib12","first-page":"301","article-title":"A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review)","volume":"26","author":"Comaru-Schally","year":"2005","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2006.02.014_bib13","first-page":"115","article-title":"The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas","volume":"115","author":"Cramer","year":"1991","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.jpainsymman.2006.02.014_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(197901)43:1<294::AID-CNCR2820430142>3.0.CO;2-V","article-title":"Malignant melanoma producing serotonin","volume":"43","author":"Horai","year":"1979","journal-title":"Cancer"},{"issue":"1\u20133","key":"10.1016\/j.jpainsymman.2006.02.014_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0014-5793(01)03319-1","article-title":"Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells","volume":"511","author":"Slominski","year":"2002","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.jpainsymman.2006.02.014_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008390-200306000-00003","article-title":"Autonomous histamine metabolism in human melanoma cells","volume":"13","author":"Darvas","year":"2003","journal-title":"Melanoma Res"},{"issue":"12","key":"10.1016\/j.jpainsymman.2006.02.014_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1471-4906(01)02050-6","article-title":"Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation","volume":"22","author":"Falus","year":"2001","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2006.02.014_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2133.1998.02263.x","article-title":"Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic naevi","volume":"138","author":"Nagahama","year":"1998","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2006.02.014_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0560.1998.tb01682.x","article-title":"The neuropeptide\/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions","volume":"25","author":"Khare","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jpainsymman.2006.02.014_bib20","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1158\/1078-0432.CCR-03-0368","article-title":"Expression of thyrotropin-releasing hormone by human melanoma and nevi","volume":"10","author":"Ellerhorst","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jpainsymman.2006.02.014_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00000478-199905000-00013","article-title":"Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case","volume":"23","author":"Banerjee","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2006.02.014_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00008390-199808000-00011","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone in a patient affected by metastatic melanoma","volume":"8","author":"Lo Scocco","year":"1998","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.jpainsymman.2006.02.014_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5694\/j.1326-5377.1986.tb128396.x","article-title":"Fatal inappropriate ADH secretion in melanoma","volume":"144","author":"Kefford","year":"1986","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.jpainsymman.2006.02.014_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clon.2005.01.002","article-title":"Malignant melanoma and SIADH","volume":"17","author":"Sanghera","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.jpainsymman.2006.02.014_bib25","first-page":"1240","article-title":"Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid","volume":"46","author":"Koopmans","year":"2005","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.jpainsymman.2006.02.014_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004836-200301000-00031","article-title":"Carcinoid crisis induced by external manipulation of liver metastasis","volume":"36","author":"Kharrat","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2006.02.014_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004311-199703540-00009","article-title":"Anesthesia for patients with carcinoid syndrome","volume":"35","author":"Vaughan","year":"1997","journal-title":"Int Anesthesiol Clin"},{"issue":"25","key":"10.1016\/j.jpainsymman.2006.02.014_bib28","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1056\/NEJM200306193482519","article-title":"The chromogranin-secretogranin family","volume":"348","author":"Tony","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jpainsymman.2006.02.014_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2559.2005.02240.x","article-title":"Malignant melanoma with neuroendocrine differentiation: clinical, histological immunohistochemical and ultrastructural features of three cases","volume":"47","author":"Eyden","year":"2005","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.jpainsymman.2006.02.014_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002680020102","article-title":"Distribution and functional significance of somatostatin receptors in malignant melanoma","volume":"25","author":"Lum","year":"2001","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.jpainsymman.2006.02.014_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1167\/iovs.02-0481","article-title":"Expression of somatostatin receptors in uveal melanomas","volume":"44","author":"Ardjomand","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jpainsymman.2006.02.014_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jpainsymman.2004.03.002","article-title":"Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care","volume":"28","author":"Meyers","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.jpainsymman.2006.02.014_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1532-5415.2004.52209.x","article-title":"Hospice admission practices: where does hospice fit in the continuum of care?","volume":"52","author":"Lorenz","year":"2004","journal-title":"J Am Geriatr Soc"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406003381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406003381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:57:25Z","timestamp":1760129845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392406003381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0885392406003381"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.02.014","relation":{},"ISSN":["0885-3924"],"issn-type":[{"type":"print","value":"0885-3924"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Palliation with Octreotide of a Neuroendocrine Syndrome from Malignant Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}